-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Ligand Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Ligand Pharmaceuticals Inc Operating Income (Loss) for the quarter ending September 30, 2024 was $3.14M, a 2.11% increase year-over-year.
- Ligand Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$16.3M, a 240% decline year-over-year.
- Ligand Pharmaceuticals Inc annual Operating Income (Loss) for 2023 was $11.9M, a 293% increase from 2022.
- Ligand Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was $3.04M, a 97.1% decline from 2021.
- Ligand Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was $104M, a 177% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)